SANA - Sana Biotechnology, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$8.67
DETAILS
HIGH:
$12.00
LOW:
$7.00
MEDIAN:
$7.00
CONSENSUS:
$8.67
UPSIDE:
182.41%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 0.0% |
| EBIT Margin | 0.0% |
| EBITDA Margin | 0.0% |
| Operating Margin | 0.0% |
| Pretax Margin | 0.0% |
| Cont. Ops Margin | 0.0% |
| Net Margin | 0.0% |
| Bottom Line Margin | 0.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 1.89 |
| Quick Ratio | 1.89 |
| Solvency Ratio | -0.904 |
| Cash Ratio | 0.91 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-4.22
Peers avg: 9.7
|
| PEG Ratio | 0.24 |
| Forward PEG | 0.24 |
| Price/Book | 6.41 |
| Price/Sales | 0.00 |
| Price/FCF | -7.12 |
| Price/Op Cash Flow | -7.17 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.1892 |
| Debt/Equity | 0.4902 |
| Debt/Capital | 0.3289 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 2.59 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.00 |
| Operating Cash Flow Ratio | -1.827 |
| Operating Cash Flow/Sales | 0.0% |
| Free Cash Flow/Operating Cash Flow | 100.7% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -11.93 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -9.63 |
| Operating Cash Flow Coverage | -1.82 |
| Capital Expenditure Coverage | -153.33 |
| Dividend + Capital Expenditure Coverage | -153.33 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.00 |
| EPS | -0.964 |
| Debt/Share | 0.3114 |
| Cash/Share | 0.55 |
| Book Value/Share | 0.64 |
| Tangible BV/Share | -0.15 |
| Equity/Share | 0.64 |
| Operating Cash Flow/Share | -0.568 |
| Capital Expenditure/Share | 0.004 |
| FCF/Share | -0.572 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 1.279 |
| Price/Fair Value | 6.41 |
| Debt/Market Cap | 0.0145 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -5.82 |